Johnson & Johnson (JNJ) Stock Analysis
NYSEHealth CarePharmaceuticals
What Johnson & Johnson does
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Key metrics
ETFs linked to JNJ
Broad-market and Health Care sector ETFs an investor holding Johnson & Johnson is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how JNJ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze JNJ in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Johnson & Johnson?
- Johnson & Johnson trades under the ticker JNJ on NYSE.
- Which exchange is JNJ listed on?
- JNJ is listed on NYSE.
- What sector does Johnson & Johnson operate in?
- Johnson & Johnson is classified in the Health Care sector (Pharmaceuticals industry).
- How can PortView help analyze JNJ in a portfolio?
- PortView shows JNJ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.